DIGITAL HEALTH CONSULTING

Turn digital health innovation into evidence-ready products

Navigate evolving requirements for software-driven, AI-enabled, and connected medical technologies. Our digital health specialists help define regulatory pathways, validate software and algorithm performance, and generate the evidence needed to support market authorization.

Navigate what makes digital health different

Software updates, evolving algorithms, cybersecurity risks, changing regulatory expectations, and novel evidence requirements create challenges traditional device development strategies may not fully address. IQVIA MedTech brings specialized regulatory, clinical, validation, human factors, and cybersecurity expertise to help digital health innovators build the evidence and strategy needed to accelerate market entry.

Specialized support for:

  • Software as a Medical Device (SaMD)
  • Wearables, Remote Monitoring and Connected Health Technologies
  • AI-Enabled Medical Technologies
  • Imaging and Diagnostic Solutions
  • Robotics and Intelligent Systems

Targeted consulting & solutions across the digital health lifecycle

Futuristic world map

Digital Health Regulatory Strategy & Submission Support

Navigate evolving FDA, global software, AI, and cybersecurity requirements with regulatory strategies that support development, submission, and market authorization.

  • Product classification and regulatory pathway assessment
  • FDA, EU, and other health authority interactions
  • 510(k), De Novo, PMA, EU MDR, and other submission support
  • Predetermined Change Control Plan development
  • Cybersecurity regulatory strategy and documentation

Software, Algorithm & Performance Validation

Demonstrate that software-driven and AI-enabled technologies perform safely, reliably, and consistently across intended users, populations, datasets, devices, and clinical environments.

  • Software verification and validation
  • Algorithm performance and robustness testing
  • Dataset representativeness and bias assessment
  • Data annotation and ground-truth development
  • Human factors and usability studies
  • Reader and MRMC studies

Clinical Evidence for Digital Health Technologies

We help you plan and execute clinical studies to generate evidence supporting regulatory approval, reimbursement, and commercialization.

  • Clinical evidence strategy and study design
  • Endpoint and acceptance-criteria development
  • Prospective and retrospective study execution
  • Digital endpoint and data-source strategy
  • Site and participant identification
  • Workflow and intended-use validation
  • Biostatistical analysis and regulatory reporting
Woman pointing on digital tablet screen

Market Access & Post-Market Support

Support adoption and ongoing performance through reimbursement strategy, real-world evidence, surveillance, and lifecycle management.

  • Market access & reimbursement
  • Real-world evidence
  • Post-market surveillance
  • Cybersecurity monitoring
  • Algorithm performance monitoring
  • Continuous AI optimization

AI & Imaging Specialization

From algorithm performance to regulatory evidence

A strong algorithm is only the beginning. AI and imaging innovators must demonstrate performance, generate robust evidence, and navigate evolving regulatory requirements. IQVIA MedTech combines specialized FDA regulatory, clinical, imaging, statistical, and data science expertise, from ground truth and algorithm validation to reader studies, including MRMC studies, to help accelerate regulatory approval and market entry.
From algorithm performance to regulatory evidence

The data and evidence advantage behind digital health innovation

IQVIA combines specialized digital health expertise with one of the industry's most comprehensive healthcare data and analytics ecosystems to help innovators generate evidence, validate performance, and demonstrate value throughout the product lifecycle.

Custom Photo Grid of dots and rays from a deep space sky
MCRA is now part of IQVIA MedTech
Your Strategic Partner in Regulatory Success
By uniting MCRA's specialized digital health regulatory expertise with IQVIA MedTech’s global scale, data platforms, and clinical trial infrastructure, we help you seamlessly navigate the complex software, imaging, and connected device lifecycle.

Interactive Case Study

Overview

Empowering FDA Clearance of United Imaging Intelligence Technology in Under 60 Days


REGULATORY
Digital Health


SERVICES
Scaling advanced AI medical imaging software into U.S. clinical workflows through specialized digital health and regulatory consulting.

Global medical artificial intelligence (AI) firm United Imaging Intelligence (UII) developed uAI Easy Triage ICH, an AI software platform engineered to assist radiologists by rapidly analyzing non-contrast head CT scans for acute intracranial hemorrhage (ICH), enabling faster triage in critical care environments.
Challenge

Securing U.S. market entry required validating complex machine learning algorithms, establishing software lifecycle compliance, and navigating stringent FDA mandates for computer-aided triage (CADt) devices.
To obtain FDA clearance, UII needed to prove standalone algorithm sensitivity, specificity, and operational stability. They required an expert regulatory partner to define a clear pre-market submission pathway, manage cybersecurity documentation, and structure rigorous clinical performance studies.
Solution

MCRA’s Digital Health and AI experts authored the 510(k) submission, established IEC 62304 software compliance, and designed multi-site retrospective study protocols to evaluate uAI Easy Triage ICH's triage accuracy.
MCRA led strategic pre-submission interactions with the agency to lock in study endpoints prior to formal filing. The team managed risk evaluations, cybersecurity engineering reviews, and statistical validation to demonstrate seamless workflow integration for emergency radiology.
Results

MCRA helped UII secure timely FDA 510(k) clearance for uAI Easy Triage ICH with minimal agency questions, unlocking rapid commercial deployment across U.S. radiology networks.

Key Milestones Achieved

  • FDA 510(k) Clearance: Successfully cleared uAI Easy Triage ICH for acute intracranial hemorrhage detection.
  • Streamlined Review: Early alignment with agency reviewers eliminated review bottlenecks and costly study delays.
  • Market Growth: Positioned UII to expand its broader AI software and imaging portfolio across U.S. healthcare systems.
Ready to accelerate your AI, imaging, or software submission?
Whether you are structuring early SaMD regulatory pathways, authoring a Predetermined Change Control Plan (PCCP) for iterative AI updates, or validating software performance through clinical reader studies, our digital health experts are ready to assist.

Frequently asked questions about digital health consulting and solutions

Our specialized digital health team guides software companies through device classification, IEC 62304 software lifecycle management, cybersecurity compliance, and dossier authoring for 510(k), De Novo, PMA, and EU MDR submissions. We also help structure Predetermined Change Control Plans (PCCP) to enable iterative AI updates without requiring continuous new filings.
As a specialized imaging cro, we manage end-to-end clinical trials and reader studies for diagnostic imaging software, computer-aided triage tools, surgical planning platforms, and novel modalities. Services include core lab management, protocol design, site activation, independent central reviews, and biostatistical analysis tailored to imaging endpoints.
We build integrated market access strategies that translate connected device telemetry and software outputs into actionable economic and clinical evidence. Our reimbursement team helps clients secure CPT Category I and III codes, analyze payer coverage policies, and author value dossiers for remote patient monitoring platforms and healthcare AI applications.

Related solutions